CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN TOTAL EQUITY (unaudited) - USD ($) shares in Thousands, $ in Thousands	Total		Common Shares	Capital in Excess of Stated Value	Accumulated Other Comprehensive Loss	Retained Earnings	Noncontrolling Interests
Beginning balance at Dec. 31, 2022	$ 2,072,797		$ 7,175	$ 140,539	$ (430,083)	$ 2,348,183	$ 6,983
Beginning balance (in shares) at Dec. 31, 2022			97,645
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)	148,264					148,319	(55)
Other comprehensive (loss)/income
Translation loss	31,808				31,569		239
Defined benefit plan adjustment, net of tax	916				916
Derivative financial instruments, net of tax	2,514				2,514
Other comprehensive (loss) income	35,238				34,999		239
Dividends	(48,203)					(48,203)
Issuance of stock awards	472			472
Issuance of stock awards (in shares)			485
Shares repurchased	(10,576)			(10,576)
Shares repurchased (in shares)			(175)
Share-based compensation	7,573			7,573
Ending balance at Apr. 02, 2023	2,205,565		$ 7,175	138,008	(395,084)	2,448,299	7,167
Ending balance (in shares) at Apr. 02, 2023			97,955
Beginning balance at Dec. 31, 2022	2,072,797		$ 7,175	140,539	(430,083)	2,348,183	6,983
Beginning balance (in shares) at Dec. 31, 2022			97,645
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)	263,013
Other comprehensive (loss)/income
Translation loss	53,498
Defined benefit plan adjustment, net of tax	(847)
Derivative financial instruments, net of tax	3,942
Other comprehensive (loss) income					56,652
Ending balance at Jul. 02, 2023	2,299,322		$ 7,175	145,841	(373,431)	2,512,768	6,969
Ending balance (in shares) at Jul. 02, 2023			97,956
Beginning balance at Apr. 02, 2023	2,205,565		$ 7,175	138,008	(395,084)	2,448,299	7,167
Beginning balance (in shares) at Apr. 02, 2023			97,955
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)	114,749					114,649	100
Other comprehensive (loss)/income
Translation loss	21,690				21,988		(298)
Defined benefit plan adjustment, net of tax	(1,763)				(1,763)
Derivative financial instruments, net of tax	1,428				1,428
Other comprehensive (loss) income	21,355				21,653		(298)
Dividends	(50,180)					(50,180)
Issuance of stock awards	222			222
Issuance of stock awards (in shares)			1
Shares repurchased	(26)			(26)
Shares repurchased (in shares)			0
Share-based compensation	7,637			7,637
Ending balance at Jul. 02, 2023	2,299,322		$ 7,175	145,841	(373,431)	2,512,768	6,969
Ending balance (in shares) at Jul. 02, 2023			97,956
Beginning balance at Dec. 31, 2023	$ 2,431,835	[1]	$ 7,175	159,047	(366,262)	2,624,380	7,495
Beginning balance (in shares) at Dec. 31, 2023	97,957		97,957
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)	$ 65,273					65,177	96
Other comprehensive (loss)/income
Translation loss	(19,786)				(19,319)		(467)
Defined benefit plan adjustment, net of tax	43				43
Derivative financial instruments, net of tax	169				169
Other comprehensive (loss) income	(19,574)				(19,107)		(467)
Dividends	(50,348)					(50,348)
Issuance of stock awards	204			204
Issuance of stock awards (in shares)			460
Shares repurchased	(9,139)			(9,139)
Shares repurchased (in shares)			(162)
Share-based compensation	8,325			8,325
Other	906			906
Ending balance at Mar. 31, 2024	2,427,482		$ 7,175	159,343	(385,369)	2,639,209	7,124
Ending balance (in shares) at Mar. 31, 2024			98,255
Beginning balance at Dec. 31, 2023	$ 2,431,835	[1]	$ 7,175	159,047	(366,262)	2,624,380	7,495
Beginning balance (in shares) at Dec. 31, 2023	97,957		97,957
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)	$ 156,224
Other comprehensive (loss)/income
Translation loss	(53,194)
Defined benefit plan adjustment, net of tax	2,122
Derivative financial instruments, net of tax	(1,492)
Other comprehensive (loss) income					(52,055)
Ending balance at Jun. 30, 2024	$ 2,441,867		$ 7,175	167,114	(418,317)	2,678,673	7,222
Ending balance (in shares) at Jun. 30, 2024	98,258		98,258
Beginning balance at Mar. 31, 2024	$ 2,427,482		$ 7,175	159,343	(385,369)	2,639,209	7,124
Beginning balance (in shares) at Mar. 31, 2024			98,255
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)	90,951					90,811	140
Other comprehensive (loss)/income
Translation loss	(33,408)				(33,366)		(42)
Defined benefit plan adjustment, net of tax	2,079				2,079
Derivative financial instruments, net of tax	(1,661)				(1,661)
Other comprehensive (loss) income	(32,990)				(32,948)		(42)
Dividends	(51,347)					(51,347)
Issuance of stock awards	181			181
Issuance of stock awards (in shares)			4
Shares repurchased	(23)			(23)
Shares repurchased (in shares)			(1)
Share-based compensation	6,656			6,656
Other	957			957
Ending balance at Jun. 30, 2024	$ 2,441,867		$ 7,175	$ 167,114	$ (418,317)	$ 2,678,673	$ 7,222
Ending balance (in shares) at Jun. 30, 2024	98,258		98,258

[1] The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (the “United States” or “U.S.”).